SNST (Aphex BioCleanse Systems) Total Current Liabilities: $0.00 Mil (As of . 20)


What is Aphex BioCleanse Systems Total Current Liabilities?

Aphex BioCleanse Systems SNST Total Current Liabilities is $0.00 Mil as of . 20.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Aphex BioCleanse Systems's total current liabilities for the quarter that ended in . 20 was $0.00

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Aphex BioCleanse Systems Total Current Liabilities Related Terms

Aphex BioCleanse Systems Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Total Current Liabilities Chart

Aphex BioCleanse Systems Annual Data
Trend
Total Current Liabilities

Aphex BioCleanse Systems Quarterly Data
Total Current Liabilities

Aphex BioCleanse Systems Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Aphex BioCleanse Systems's Total Current Liabilities for the fiscal year that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

Aphex BioCleanse Systems's Total Current Liabilities for the quarter that ended in . 20 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=+
+Other Current Liabilities+Current Deferred Liabilities
=+
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $0.00 Mil mean?
Aphex BioCleanse Systems (SNST) has a Total Current Liabilities of $0.00 Mil as of . 20. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Total Current Liabilities too high?
Aphex BioCleanse Systems' current Total Current Liabilities is $0.00 Mil.
How does Aphex BioCleanse Systems' Total Current Liabilities compare to competitors?
Aphex BioCleanse Systems' Total Current Liabilities of $0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Consumer Packaged Goods company?
A good Total Current Liabilities depends on the Consumer Packaged Goods industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Aphex BioCleanse Systems and its competitors. Aphex BioCleanse Systems's current Total Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Total Current Liabilities of $0.00 Mil. The current Total Current Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Total Current Liabilities is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.